Epigenetic analysis of 6-base genome in Parkinson’s

The emergence of the ‘6-base genome’, which includes the modified bases 5-methylcytosine (5mC) and its oxidised form, 5-hydroxymethylcytosine (5hmC), marks a significant evolution in our understanding of genetic and epigenetic regulation.

In this webinar, Burleen Chhatwal from University College London, UK, demonstrates how biomodal’s 6-base genome supported the successful analysis of both 5mC and 5hmC modifications in Parkinson’s disease compared to controls in a pilot study.